Morphological and functional changes due to drug-induced lysosomal storage of sulphated glycosaminoglycans in the rat retina.
A series of dicationic amphiphilic drugs, most of them immunomodulatory agents, are known to induce generalised lysosomal storage of sulphated glycosaminoglycans (GAGs) in rats and in cultured cells of several species including man. The present study deals with the cytological effects of two experimental immunomodulatory acridine derivatives upon the retina of rats. The animals were treated orally with compound CL-90.100 (3,6-bis[2-(diethylamino)ethoxy]acridine) or an analogue for periods up to 22 weeks at a dose range of 60-90 mg/kg body weight and the retinae examined by light and electron microcopy. ERG measurements were done initially and after 16 weeks of treatment. All types of retinal cells developed abnormal cytoplasmic vacuoles which represented the ultrastructural counterpart of lysosomal GAG storage as demonstrated by histochemical and cytochemical staining experiments. The retinal pigment epithelium and the Müller cells were most prominently affected, photoreceptor cells to a lesser degree, and retinal neurons to varying degrees. The topographical distribution of the drug as detected by fluorescence microscopy closely resembled the distribution of the GAG accumulation in the retinal layers. After treatment for 16 weeks, the a-and b-wave amplitudes in the ERG were significantly reduced compared with the controls.


CONCLUSIONS
the glycosaminoglycan storage in pigment epithelium is reminiscent of that seen in some inherited mucopolysaccharidoses of humans. When a given cell type shows lysosomal accumulation of glycosaminoglycans as a consequence of impaired degradation, it can be assumed to be engaged in the turnover of glycosaminoglycans under normal conditions. Thus the present results suggest that not only the retinal pigment epithelium but also Müller cells, photoreceptor cells, and, to variable degree, retinal neurons are normally involved in the catabolism of sulphated glycosaminoglycans. We believe that the lysosomal storage of glycosaminoglycans caused secondary cellular disturbance responsible for the functional changes shown by electroretinography.
Bredehorn
T
T
Department of Ophthalmology, University of Halle-Wittenberg, Halle-Saale, Germany. timm.bredehorn@dso.de
Clausen
M
M
Duncker
G
G
Lüllmann-Rauch
R
R
D000166:Acridines / Q000633:toxicity; D000276:Adjuvants, Immunologic / Q000633:toxicity; D000818:Animals; D003593:Cytoplasm / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D004596:Electroretinography; D005260:Female; D006025:Glycosaminoglycans / Q000378:metabolism*; D008247:Lysosomes / Q000378:metabolism* / Q000473:pathology; D008856:Microscopy, Fluorescence; D009083:Mucopolysaccharidoses / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D010857:Pigment Epithelium of Eye / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D051381:Rats; D017208:Rats, Wistar; D012160:Retina / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D012164:Retinal Diseases / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D014617:Vacuoles / Q000378:metabolism / Q000473:pathology
D000166:Acridines; D000276:Adjuvants, Immunologic; D006025:Glycosaminoglycans; C013786:A73025; C075219:3,6-bis(2-(diethylamino)ethoxy)acridine